🟢 Amneal Pharmaceuticals is trading 4.02% up in pre-market amid healthcare's 1.32% pre-market gain

Amneal Pharmaceuticals is trading at $21.99, up 4.02%, with healthcare sector strength the clearest available context for its pre-market rise.

• Healthcare was up 1.32% pre-market.
• No company-specific announcement explaining the October 29 pre-market rise was identified.
• Third-quarter results are scheduled for November 3, not October 29; the upcoming report is not a confirmed same-day catalyst.